IBA Treatment in Adolescents With OCD
Primary Purpose
Obsessive-Compulsive Disorder in Adolescence
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Inference Based Approach (IBA)
Sponsored by
About this trial
This is an interventional treatment trial for Obsessive-Compulsive Disorder in Adolescence
Eligibility Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Primary DSM-5 diagnosis of OCD.
- A total score of 16 or higher on the CY-BOCS.
- Age between 12 and 17;11.
- A completed evidence-based treatment for OCD.
- Medication must be stable for at least one month.
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- No sufficient knowledge of the Dutch language
- Autism spectrum disorder (ASD)**
- Mental retardation (TIQ<80)**
Acute suicidality (defined as having suicidal thoughts and plans and/or preparations to ending their life)
- In case of ASD and/or mental retardation, the IBA protocol maybe too challenging. It is expected that the included cognitive elements, specifically when abstract reasoning is asked, will ask too much of these subjects.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
A non-concurrent multiple baseline design
Arm Description
A non-concurrent multiple baseline design
Outcomes
Primary Outcome Measures
Change in severity of OCD
measured with the CY-BOCS at T0 = Study intake (baseline phase);T1 = Start treatment phase; i.e. start IBA treatment; T2 = Post-treatment assessment (after IBA treatment); T3 = Follow-up 3 months post-treatment
Secondary Outcome Measures
Change in OCD symptomatology
measured with three-weekly ratings of the adolescents' obsessions, compulsions and the level of insight.
Treatment history (psychotherapy and medication)
Treatment history (psychotherapy and medication)
Change in current medication use
Current medication use at T0 = Study intake (baseline phase) T1 = Start treatment phase; i.e. start IBA treatment T2 = Post-treatment assessment (after IBA treatment) T3 = Follow-up 3 months post-treatment
Full Information
NCT ID
NCT05547334
First Posted
September 14, 2022
Last Updated
September 20, 2022
Sponsor
Karakter Kinder- en Jeugdpsychiatrie
1. Study Identification
Unique Protocol Identification Number
NCT05547334
Brief Title
IBA Treatment in Adolescents With OCD
Official Title
Effect of Inference Based Approach in Adolescents With OCD
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2022 (Anticipated)
Primary Completion Date
November 1, 2023 (Anticipated)
Study Completion Date
November 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Karakter Kinder- en Jeugdpsychiatrie
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions, compulsions or both. OCD is a severe psychiatric disorder, affecting many aspects of the lives of adolescents. The first choice treatment for adolescents with OCD is Cognitive Behavioral Therapy (CBT), consisting of exposure with response prevention (ERP) and cognitive interventions. Considering the substantial group of non-responders to CBT, it is necessary to have more options for effective treatment of OCD. Inference Based Approach (IBA) is already an effective treatment for adults with OCD and is more effective on adults with OCD and poor cognitive insight. It is hypothesized that IBA could be an effective alternative for CBT in treating adolescents with OCD. This study will be a first step in examining the efficacy of IBA as treatment for adolescents with OCD.
The aim of this study is to explore the potential efficacy of IBA as treatment for adolescents with OCD using a non-concurrent multiple baseline design with 8 participants who receive IBA for 20 sessions performed in one psychiatric centre in the Netherlands.
Detailed Description
Background of the study:
Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions, compulsions or both (APA, 2014). OCD is a severe psychiatric disorder, affecting many aspects of the lives of adolescents (Weidle et al., 2014; Storch et al., 2018). The first choice treatment for adolescents with OCD is Cognitive Behavioral Therapy (CBT), consisting of exposure with response prevention (ERP) and cognitive interventions (Öst et al., 2016). Treating adolescents with OCD through CBT leads to significant symptom reduction in almost 70% of completed treatments (Öst et al., 2016). However, after completion of treatment, about 50% of adolescents still meet the criteria for OCD (Öst et al., 2016). Adolescents with OCD who do not sufficiently benefit from CBT treatment have severe symptoms, including poor or no insight (Sharma et al., 2021; Nissen & Parner, 2018; Storch et al., 2014). Considering the substantial group of non-responders to CBT, it is necessary to have more options for effective treatment of OCD. Inference Based Approach (IBA) is already an effective treatment for adults with OCD (O'Connor et al., 2005; Visser et al., 2015) and is more effective on adults with OCD and poor cognitive insight (Visser et al., 2015). It is hypothesized that IBA could be an effective alternative for CBT in treating adolescents with OCD. This study will be a first step in examining the efficacy of IBA as treatment for adolescents with OCD.
Objective of the study:
The aim of this study is to explore the potential efficacy of IBA as treatment for adolescents with OCD.
Study design:
A non-concurrent multiple baseline design with 8 participants who receive IBA for 20 sessions perfomed in one psychiatric centre in the Netherlands.
Study population:
8 adolescents from 12 to 17;11 years old with a Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-5) diagnosis of OCD and a total score of 16 or higher on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). All adolescents included in this study completed an evidence-based treatment for OCD prior to participation.
Intervention (if applicable):
20 sessions IBA treatment.
Primary study parameters/outcome of the study:
Severity of OCD, measured with the CY-BOCS;
Secondary study parameters/outcome of the study (if applicable):
OCD symptomatology, measured with three-weekly ratings of the adolescents' obsessions, compulsions and the level of insight.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness (if applicable):
No burden or risks are expected due to specific elements of the IBA intervention used in this study. Contrary to CBT, treatment elements of IBA will not include exposure to feared consequences while trying to not indulge in compulsions. On top of that, obsessions will not be questioned or challenged. These characteristics may help participants stay motivated to complete treatment and experience improvement in OCD-symptoms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obsessive-Compulsive Disorder in Adolescence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
A non-concurrent multiple baseline design
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
A non-concurrent multiple baseline design
Arm Type
Other
Arm Description
A non-concurrent multiple baseline design
Intervention Type
Behavioral
Intervention Name(s)
Inference Based Approach (IBA)
Intervention Description
The Inference Based Approach (IBA) (as described by Visser et al., 2015 and adapted for use in adolescents by L. Webers)is a focused form of psychotherapy consists of twenty 45-minutes sessions, delivered weekly and carried out as specified in a Dutch session-by-session IBA protocol, containing standardized forms for exercises and homework assignments. Each session has a standard format, starting with agenda setting and evaluating homework assignments, followed by determining and executing a new exercise and determining new homework. The IBA model is based on the assumption that adolescents with OCD and poor inside misjudge the actual state of affairs. It is assumed that certain reasoning processes lead to these erroneous conclusions and distract the childs attention from observable reality.
Primary Outcome Measure Information:
Title
Change in severity of OCD
Description
measured with the CY-BOCS at T0 = Study intake (baseline phase);T1 = Start treatment phase; i.e. start IBA treatment; T2 = Post-treatment assessment (after IBA treatment); T3 = Follow-up 3 months post-treatment
Time Frame
through study completion, an average of 9 months
Secondary Outcome Measure Information:
Title
Change in OCD symptomatology
Description
measured with three-weekly ratings of the adolescents' obsessions, compulsions and the level of insight.
Time Frame
three-weekly questions during the intervention
Title
Treatment history (psychotherapy and medication)
Description
Treatment history (psychotherapy and medication)
Time Frame
T0 = Study intake (baseline phase)
Title
Change in current medication use
Description
Current medication use at T0 = Study intake (baseline phase) T1 = Start treatment phase; i.e. start IBA treatment T2 = Post-treatment assessment (after IBA treatment) T3 = Follow-up 3 months post-treatment
Time Frame
through study completion, an average of 9 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
Primary DSM-5 diagnosis of OCD.
A total score of 16 or higher on the CY-BOCS.
Age between 12 and 17;11.
A completed evidence-based treatment for OCD.
Medication must be stable for at least one month.
A potential subject who meets any of the following criteria will be excluded from participation in this study:
No sufficient knowledge of the Dutch language
Autism spectrum disorder (ASD)**
Mental retardation (TIQ<80)**
Acute suicidality (defined as having suicidal thoughts and plans and/or preparations to ending their life)
In case of ASD and/or mental retardation, the IBA protocol maybe too challenging. It is expected that the included cognitive elements, specifically when abstract reasoning is asked, will ask too much of these subjects.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
L.A.A.C. Webers, Msc
Phone
06-31915818
Email
l.webers@karakter.com
First Name & Middle Initial & Last Name or Official Title & Degree
H Klip, Phd
Phone
06-31915818
Email
h.klip@karakter.com
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
IBA Treatment in Adolescents With OCD
We'll reach out to this number within 24 hrs